Chemical Compound

Atorvastatin lactone

CAS Registry Number 125995-03-1
Back to search Request a Quote
Atorvastatin lactone chemical structure
Primary Record

Atorvastatin lactone

In stock
9,802 g
Purity
99.0 %
CAS
125995-03-1

Compound Identifiers & Properties

CAS
125995-03-1
PubChem CID
6483036
SMILES
CC(C)C1=C(C(=C(N1CC[C@@H]2C[C@H](CC(=O)O2)O)C3=CC=C(C=C3)F)C4=CC=CC=C4)C(=O)NC5=CC=CC=C5
Canonical SMILES
CC(C)c1c(C(=O)Nc2ccccc2)c(-c2ccccc2)c(-c2ccc(F)cc2)n1CC[C@@H]1C[C@@H](O)CC(=O)O1

Names & Synonyms

  • Atorvastatin lactone
  • 125995-03-1
  • atorvastatin
  • Impurity H
  • Ethylmorphine-d5
  • Atorvastatin EP Impurity H
  • Atorvastatin delta-Lactone
  • RefChem:5572
  • Atorvastatin IMpurity H
  • Atorvastatin-d5 Lactone
  • Atorvastatin |A-Lactone
  • UNII-7876IL7J2N
  • AC1O5EXB
  • MFCD00899262
  • C33H33FN2O4
  • CHEMBL333687
  • 7876IL7J2N
  • Atorvastatin Related Compound H
  • MLS006010799
  • 4-Methylumbelliferyl palmitate
  • DTXSID90155033
  • OUCSEDFVYPBLLF-KAYWLYCHSA-N
  • GTPL2957
  • orb1308630
  • SCHEMBL1258955
  • Atorvastatin lactone (Standard)
  • DTXCID4077524
  • CTK8E9694
  • (+)-ATORVASTATIN LACTONE
  • ATORVASTATIN LACTONE [MI]
  • CHEBI:233896
  • AIDS342648
  • KS-00000FO2
  • ZINC3920720
  • BDBM50011032
  • AKOS015896169
  • CID6483036
  • CS-O-07292
  • DS-4553
  • HY-101873R
  • IA18019
  • AN-32668
  • AT-22018
  • DA-50780
  • SC-98572
  • SMR002529529
  • SY234229
  • 1044582 USP Atorvastatin Related Compound H
  • HY-101873
  • J360.189G
  • RT-011336
  • A3114
  • CS-0022115
  • NS00124192
  • 1H-Pyrrole-3-carboxamide, 5-(4-fluorophenyl)-2-(1-methylethyl)-N,4-diphenyl-1-[2-[(2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethyl]-
  • 5-(4-fluorophenyl)-1-[2-[(2R,4R)-4-hydroxy-6-oxooxan-2-yl]ethyl]-N,4-diphenyl-2-propan-2-ylpyrrole-3-carboxamide
  • F52842
  • ATORVASTATIN RELATED COMPOUND H (USP-RS)
  • ATORVASTATIN RELATED COMPOUND H [USP-RS]
  • 995A031
  • A805452
  • F601118
  • 5-(4-Fluorophenyl)-2-(1-methylethyl)-N,4-diphenyl-1-[2-[(2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethyl]-1H-pyrrole-3-carboxamide
  • I06-1682
  • ATORVASTATIN CALCIUM IMPURITY H [EP IMPURITY]
  • ATORVASTATIN RELATED COMPOUND H (USP IMPURITY)
  • ATORVASTATIN RELATED COMPOUND H [USP IMPURITY]
  • Q27074604
  • 5-(4-fluorophenyl)-1-(2-((2R,4R)-4-hydroxy-6-oxotetrahydro-2H-pyran-2-yl)ethyl)-2-isopropyl-N,4-diphenyl-1H-pyrrole-3-carboxamide
  • 5-(4-fluorophenyl)-1-[2-[(2R,4R)-4-hydroxy-6-oxo-tetrahydropyran-2-yl]ethyl]-2-isopropyl-N,4-diphenyl-pyrrole-3-carboxamide
  • 5-(4-fluorophenyl)-1-{2-[(2R,4R)-4-hydroxy-6-oxooxan-2-yl]ethyl}-N,4-diphenyl-2-(propan-2-yl)-1H-pyrrole-3-carboxamide
  • Atorvastatin EP Impurity H; USP Atorvastatin Related Compound H
  • (4R,6R)-6-[2-[2-(4-Fluorophenyl)-5-(1-methylethyl)-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl]ethyl]-4-hydroxytetrahydro-2H-pyran-2-one (Atorvastatin Lactone)
  • 1H-Pyrrole-3-carboxamide, 5-(4-fluorophenyl)-2-(1-methylethyl)-N,4-diphenyl-1-(2-((2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl)-
  • 5-(4-Fluorophenyl)-1-[2-[(2R,4R)-4-hydroxy-6-oxotetrahydro-2H-pyran-2-yl]ethyl]-2-isopropyl-N,4-diphenyl-1H-pyrrole-3-carboxamide
  • 5-(4-Fluorophenyl)-1-{2-[(2R, 4R)-4-hydroxy-6-oxotetrahydro-2H-pyran-2-yl]ethyl}-2-isopropyl-N,4-diphenyl-1H-pyrrole-3-carboxamide
  • (2R trans)-5 (4-fluorophenyl)-2 (1-methylethyl) -N,4-diphenyl-1-[2-(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl]-1H-pyrrole-3-carboxamide
  • (2R-trans)-5-(4-fluorophenyl)-2(1-methylethyl)-N,4-diphenyl-1-[2-(tetrahydro-4hydroxy-6-oxo-2H-pyran-2-yl)-ethyl]-1H-pyrrole-3carboxamide
  • (2R-Trans)-5-(4-fluorophenyl)-2-(1-methyl -ethyl)-N,4-diphenyl-1-[2-(tetrahydro-4-hydroxy-6-oxo -2H-pyran-2-yl)ethyl]-1H-pyrrole-3-carboxamide
  • (2R-trans)-5-(4-fluorophenyl)-2-(1-methyl-ethyl)-N,4-diphenyl-1-[2-(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl]-1H-pyrrole-3-carboxamide
  • (2R-trans)-5-(4-fluorophenyl)-2-(1-methylethyl)-N,4-diphenyl-1-[2-(tetrahydro -4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl]-1H-pyrrole-3-carboxamide
  • (2R-trans)-5-(4-fluorophenyl)-2-(1-methylethyl)-N,4-diphenyl-1-[2-(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)-ethyl]-1H-pyrrole-3-carboxamide
  • (2R-trans)-5-(4-fluorophenyl)-2-(1-methylethyl)-N,4-diphenyl-1-[2-(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)-ethyl]-1H-pyrrole-3carboxamide
  • (2R-trans)-5-(4-fluorophenyl)-2-(1-methylethyl)-N,4-diphenyl-1-[2-(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)-ethyl]1H-pyrrole-3-carboxamide
  • (2R-trans)-5-(4-fluorophenyl)-2-(1-methylethyl)-N,4-diphenyl-1-[2-(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl]-1H-pyrrole-3-carboxamide
  • (2R-trans)-5-(4-fluorophenyl)-2-(1-methylethyl)-N,4-diphenyl-1-[2-(tetrahydro-4-hydroxy-6-oxo2H-pyran-2-yl)ethyl]-1H-pyrrole-3-carboxamide
  • (3R,5R)-7-[2-(4-Fluorophenyl)-5-isopropyl-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-yl]-3,5-dihydroxyheptanoic acid 1,5-lactone
  • (4R,6R)-6-[2-[2-(4-fluorophenyl)-5-(1-methylethyl)-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl]ethyl]-4-hydroxytetrahydro-2H-pyran-2-one
  • 1-[2-(4beta-Hydroxy-6-oxotetrahydro-2H-pyran-2alpha-yl)ethyl]-2-(4-fluorophenyl)-N,3-diphenyl-5-isopropyl-1H-pyrrole-4-carboxamide
  • 1-[2-[[(2R)-Tetrahydro-4beta-hydroxy-6-oxo-2H-pyran]-2alpha-yl]ethyl]-5-(4-fluorophenyl)-2-isopropyl-4,N-diphenyl-1H-pyrrole-3-carboxamide
  • 1309441-17-5
  • 134523-00-5
  • 148146-51-4
  • 17695-48-6
  • 1H-PYRROLE-3-CARBOXAMIDE, 5-(4-FLUOROPHENYL)-2-(1-METHYLETHYL)-N,4-DIPHENYL-1-(2-(TETRAHYDRO-4-HYDROXY-6-OXO-2H-PYRAN-2-YL)ETHYL)-, (2R-TRANS)-
  • 1H-Pyrrole-3-carboxamide, 5-(4-fluorophenyl)-2-(1-methylethyl)-N,4-diphenyl-1-[2-(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl]-, (2R-trans)-
  • 418-950-3
  • 5-(4-Fluoro-phenyl)-1-[2-(4-hydroxy-6-oxo-tetrahydro-pyran-2-yl)-ethyl]-2-isopropyl-4-phenyl-1H-pyrrole-3-carboxylic acid phenylamide
  • 5-(4-FLUOROPHENYL)-1-(2-((2R,4R)-4-HYDROXY-6-OXOTETRAHYDROPYRAN-2-YL)ETHYL)-2-ISOPROPYL-4-PHENYL-1H-PYRROLE-3-CARBOXYLIC ACID PHENYLAMIDE
  • 5-(4-fluorophenyl)-1-[2-((2R,4R)-4-hydroxy -6-oxo-tetrahydro-pyran-2-yl)-ethyl]-2-isopropyl-4-phenyl-1H-pyrrole-3-carboxylic acid phenylamide
  • 5-(4-fluorophenyl)-1-[2-((2R,4R)-4-hydroxy-6-oxo-tetrahydro-pyran -2-yl)-ethyl]-2-isopropyl-4-phenyl-1H-pyrrole-3-carboxylic acid phenylamide
  • 5-(4-fluorophenyl)-1-[2-((2R,4R)-4-hydroxy-6-oxo-tetrahydro-pyran-2-yl)-ethyl]-2-isopropyl-4-phenyl-1H-pyrrole-3-carboxylic acid phenylamide
  • 5-(4-fluorophenyl)-1-[2-((2R,4R)4-hydroxy-6-oxo-tetrahydro-pyran-2-yl)-ethyl]-2-isopropyl-4-phenyl-1H-pyrrole-3-carboxylic acid phenylamide
  • 5-(4-Fluorophenyl)-1-[2-(4beta-hydroxy-6-oxotetrahydro-2H-pyran-2alpha-yl)ethyl]-2-isopropyl-N,4-diphenyl-1H-pyrrole-3-carboxamide
  • 5-(4-fluorophenyl)-1-[2-[(2r,4r)-4-hydroxy-6-oxotetrahydropyran-2-yl]ethyl]-2-isopropyl-4-phenyl-1h-pyrrole-3-carboxylic acid phenylamide
  • 5-(4-fluorophenyl)-1-[2-[(2S,4R)-4-hydroxy-6-oxo-2-oxanyl]ethyl]-N,4-diphenyl-2-propan-2-yl-3-pyrrolecarboxamide
  • 5-(4-luorophenyl)-1-[2-[(2R,4R)-4-hydroxy-6-oxooxan-2-yl]ethyl]-N,4-diphenyl-2-propan-2-ylpyrrole-3-carboxamide
  • Atorvastatin Calcium Trihydrate Imp. H (EP); Atorvastatin Imp. H (EP); Atorvastatin USP Related Compound H; Atorvastatin USP RC H; (4R,6R)-6-[2-[2-(4-Fluorophenyl)-5-(1-methylethyl)-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl]ethyl]-4-hydroxytetrahydro-2H-pyran-2-one; Atorvastatin Lactone; Atorvastatin Related Compound H; Atorvastatin Calcium Trihydrate Impurity H; Atorvastatin Impurity H
  • Atorvastatin USP Related Compound H; Atorvastatin Lactone; 5-(4-Fluorophenyl)-2-(1-methylethyl)-N,4-diphenyl-1-[2-[(2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethyl]-1H-pyrrole-3-carboxamide; Atorvastatin ?-Lactone
  • Lactone Impurity; 5-(4-fluorophenyl)-1-(2-((2R,4R)-4-hydroxy-6-oxotetrahydro-2H-pyran-2-yl)ethyl)-2-isopropyl-N,4-diphenyl-1H-pyrrole-3-carboxamide
  • N,4-Diphenyl-1-[2-[(2R)-4beta-hydroxy-6-oxotetrahydro-2H-pyran-2alpha-yl]ethyl]-2-isopropyl-5-(4-fluorophenyl)-1H-pyrrole-3-carboxamide